Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus

BMC Microbiology

Volumn 11, Issue , 2011, Pages

  Costa, Sofia ^a,b   Falcão, Celeste ^a   Viveiros, Miguel ^a,c   MacHado, Diana ^a,d   Martins, Marta ^a,d,e   Melo Cristino, José ^f   Amaral, Leonard ^a,c,d   Couto, Isabel ^a,b  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c COST ACTION BM0701 ^*  (Portugal)

^d INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

^f UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CHLORPROMAZINE; CIPROFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESERPINE; RNA; THIORIDAZINE; VERAPAMIL; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; CARRIER PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; MDEA GENE; MEPA GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NORA GENE; NORB GENE; NORC GENE; PORTUGAL; PULSED FIELD GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMR GENE; STAPHYLOCOCCUS AUREUS; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MUTATION; STAPHYLOCOCCUS INFECTION;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA GYRASE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 80054939368     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-11-241     Document Type: Article

References (35)

1. Epidemiology and susceptibility of 3051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. Fluit AC, Wielders CLC, Verhoef J, Schmitz FJ, J Clin Microbiol 2005 39 3727 3732 (Pubitemid 32954532)
2. Infections caused by Gram-positive bacteria: a review of the global challenge. Woodford N, Livermore DM, J Infect 2009 59 S1 4 S16 19766888
3. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Ferrero L, Cameron B, Crouzet J, Antimicrob Agents Chemother 1995 39 1554 1558 7492103
4. Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus. Ng EY, Trucksis M, Hooper DC, Antimicrob Agents Chemother 1996 40 1881 1888 8843298 (Pubitemid 26277810)
5. Mutations in the gyrA and grlA genes of quinolone-resistant clinical isolates of methicillin-resistant Staphylococcus aureus. Takahata M, Yonezawa M, Kurose S, Futakuchi N, Matsubara N, Watanabe Y, Narita H, J Antimicrob Chemother 1996 38 543 546 10.1093/jac/38.3.543 8889728 (Pubitemid 26381672)
6. Quinolone resistance: much more than predicted. Hernández A, Sánchez MB, Martínez JL, Front Microbiol 2011 2 22
7. Efflux pumps as antimicrobial resistance mechanisms. Poole K, Ann Med 2007 39 162 176 10.1080/07853890701195262 17457715 (Pubitemid 46676478)
8. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. Yoshida H, Bogaki M, Nakamura S, Ubukata K, Konno M, J Bacteriol 1990 172 6942 6949 2174864
9. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Kaatz GW, Seo SM, O'Brien L, Wahiduzzaman M, Foster TJ, Antimicrob Agents Chemother 2000 44 1404 1406 10.1128/AAC.44.5.1404- 1406.2000 10770791 (Pubitemid 30228334)
10. Efflux-related resistance to norfloxacin, dyes and biocides in bloodstream isolates of Staphylococcus aureus. DeMarco CE, Cushing LA, Frempong-Manso E, Seo SM, Jaravaza TAA, Kaatz GW, Antimicrob Agents Chemother 2007 51 3235 3239 10.1128/AAC.00430-07 17576828 (Pubitemid 350067534)
11. Identification of efflux-mediated multi-drug resistance in bacterial clinical isolates by two simple methods. Martins M, Couto I, Viveiros M, Amaral L, Antibiotic Resistance Protocols New York: Humana Press, Gillespie SH, McHugh TD, 2010 143 158 [Walker JM (Series Editor): Methods in Molecular Biology, vol. 642.]
12. Identification of efflux pump-mediated multidrug-resistant bacteria by the Ethidium Bromide-agar Cartwheel Method. Martins M, Viveiros M, Couto I, Costa SS, Pacheco T, Fanning S, Pagès JM, Amaral L, In Vivo 2011 25 171 178 21471531
13. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide. Couto I, Costa SS, Viveiros M, Martins M, Amaral L, J Antimicrob Chemother 2008 62 504 513 10.1093/jac/dkn217 18511413
14. Evaluation of efflux activity of bacteria by a semi-automated fluorometric system. Viveiros M, Rodrigues L, Martins M, Couto I, Spengler G, Martins A, Amaral L, Antibiotic Resistance Protocols New York: Humana Press, Gillespie SH, McHugh TD, 2010 159 172 [Walker JM (Series Editor)Methods in Molecular Biology, vol. 642.]
15. Mechanisms of fluoroquinolone resistance. Hooper DC, Drug Resist Updat 1999 2 38 55 10.1054/drup.1998.0068 11504468 (Pubitemid 29217093)
16. Detection of mutations in quinolone resistance-determining regions in levofloxacin- and methicillin-resistant Staphylococcus aureus: effects of the mutations on fluoroquinolone MICs. Horii T, Suzuki Y, Monji A, Morita M, Muramatsu H, Kondo Y, Doi M, Takeshita A, Kanno T, Maekawa M, Diagn Microbiol Infect Dis 2003 46 139 145 10.1016/S0732-8893(03)00037-3 12812718 (Pubitemid 36703351)
17. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B, J Clin Microbiol 1995 33 2233 2239 7494007
18. Plasmid-borne smr gene causes resistance to quaternary ammonium compounds in bovine Staphylococcus aureus. Bjorland J, Sunde M, Waage S, J Clin Microbiol 2001 39 3999 4004 10.1128/JCM.39.11.3999-4004.2001 11682521 (Pubitemid 33029774)
19. Inability of a reserpine-based screen to identify strains overexpressing efflux pump genes in clinical isolates of Staphylococcus aureus. Frempong-Manso E, Raygada JL, DeMarco CE, Seo SM, Kaatz GW, Int J Antimicrob Agents 2008 33 360 363 19097759
20. Ethidium bromide MIC screening for enhanced efflux pump gene expression or efflux activity in Staphylococcus aureus. Patel D, Kosmidis C, Seo SM, Kaatz GW, Antimicrob Agents Chemother 2010 54 5070 5073 10.1128/AAC.01058-10 20855743
21. Ethidium bromide transport across Mycobacterium smegmatis cell wall: correlation with antibiotic resistance. Rodrigues L, Ramos J, Couto I, Amaral L, Viveiros M, BMC Microbiol 2011 11 35 10.1186/1471-2180-11-35 21332993
22. Multidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyes. Huet AA, Raygada JL, Mendiratta K, Seo SM, Kaatz GW, Microbiol 2008 154 3144 3153 10.1099/mic.0.2008/021188-0
23. New methods for the identification of efflux mediated MDR bacteria, genetic assessment of regulators and efflux pump constituents, characterization of efflux systems and screening of inhibitors of efflux pumps. Viveiros M, Martins M, Couto I, Rodrigues L, Spengler G, Martins A, Kristiansen JE, Molnar J, Amaral L, Curr Drug Targets 2008 9 760 768 10.2174/138945008785747734 18781922
24. An instrument-free method for the demonstration of efflux pump activity of bacteria. Martins M, Santos B, Martins A, Viveiros M, Couto I, Cruz A, The Management Committee Members of Cost B16 of the European Commission/European Science Foundation, Pagès JM, Molnár J, Fanning S, Amaral L, In Vivo 2006 20 657 664 17091774 (Pubitemid 44680200)
25. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Performance standards for antimicrobial susceptibility testing; Seventeenth Informational Supplement M100-S17. Wayne, PA:CLSI 2007 21935774
26. Bacterial efflux systems and efflux pumps inhibitors. Marquez B, Biochimie 2005 87 1137 1147 10.1016/j.biochi.2005.04.012 15951096 (Pubitemid 41572643)
27. Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli. Paixão L, Rodrigues L, Couto I, Martins M, Fernandes P, de Carvalho CCCR, Monteiro GA, Sansonetty F, Amaral L, Viveiros M, J Biol Eng 2009 3 18 10.1186/1754-1611-3-18 19835592
28. Demonstration of intrinsic efflux activity of E. coli K-12 AG100 by an automated ethidium bromide method. Viveiros M, Martins A, Paixão L, Rodrigues L, Martins M, Couto I, Fähnrich E, Kern WV, Amaral L, Int J Antimicrob Agents 2008 35 458 462
29. Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Chung M, de Lencastre H, Matthews P, Tomasz A, Adamsson I, Aires de Sousa M, Camou T, Cocuzza C, Corso A, Couto I, Dominguez A, Gniadkowski M, Goering R, Gomes A, Kikuchi K, Marchese A, Mato R, Melter O, Oliveira D, Palacio R, Sá-Leão R, Santos Sanches I, Song JH, Tassios PT, Villari P, Microb Drug Resist 2000 6 189 198 10.1089/mdr.2000.6.189 11144419
30. Organization of the antiseptic resistance gene qacA and Tn552-related -lactamase genes in multidrug-resistant Staphylococcus haemolyticus strains of animal and human origins. Anthonisen IL, Sunde M, Steinum TM, Sidhu MS, Sørum H, Antimicrob Agents Chemoter 2002 46 3606 3612 10.1128/AAC.46.11.3606-3612.2002 (Pubitemid 35192933)
31. -CT method. Livak KJ, Schmittgen TD, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609 (Pubitemid 34164012)
32. Prevalence of two different genes encoding NorA in 23 clinical strains of Staphylococcus aureus. Sierra JM, Ruiz J, de Anta MTJ, Vila J, J Antimicrob Chemother 2000 46 145 146 10.1093/jac/46.1.145 10882706 (Pubitemid 30466213)
33. Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus. Huang J, O'Toole PW, Shen W, Amrine-Madsen H, Jiang X, Lobo N, Palmer LM, Voelker L, Fan F, Gwynn MN, McDevitt D, Antimicrob Agents Chemother 2004 48 909 917 10.1128/AAC.48.3.909-917.2004 14982783 (Pubitemid 38280343)
34. 16S/23S rRNA sequencing. Lane DJ, Nucleic acid techniques in bacterial systematics London: John Wiley & Sons Ltd, Stackebrant E, Goodfellow M, 1991 115 175
35. Small-colony mutants of Staphylococcus aureus allow selection of gyrase-mediated resistance to dual-target fluoroquinolones. Pan XS, Hamlyn PJ, Talens-Visconti R, Alovero FL, Manzo RH, Fisher LM, Antimicrob Agents Chemother 2002 46 2498 2506 10.1128/AAC.46.8.2498-2506.2002 12121924 (Pubitemid 34793455)